← Eichor
Study identifier: NCT07418125 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Condition: Breast Cancer  ·  Sponsor: Institute of Oncology Ljubljana

PhaseNA
Planned participants130
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

This description comes directly from the study's public registry record.

Talk to the study team

Klavdija Korošec  ·  00386 1 5879 639  ·  kkorosec@onko-i.si

Neza Gros  ·  00386 1 5879 014  ·  ngros@onko-i.si

Always discuss trial participation with your own doctor first.

Locations (1)

Institute of Oncology LjubljanaLjubljana, SloveniaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07418125